Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species
investigated consequences of 3 nonsynonymous SNPs for FcgammaRI; only SNP V39I reduces immune-complex binding of FcgammaRI whereas monomeric IgG binding is unaffected; SNPs I301M and I338T have no influence on monomeric IgG or immune complex binding, but FcRgamma (show FCER1G ELISA Kits) signaling is decreased for both SNPs
Studies show that neutrophil CD64 (nCD64) is a reliable biomarker for diagnosing neonatal sepsis.
Data revealed that Erythema Nodosum Leprosum neutrophils express CD64, presumably contributing to the immunopathogenesis of the disease.
Our findings demonstrate that remarkable CD64 expression during Kawasaki dsease flare-ups may serve as a biomarker for diagnosis.
FCGR1A expression is significantly upregulated in human masticatory mucosa during wound healing
This study demonstrated that CD64 discriminates between critically ill patients with culture positive and negative sepsis and correlates with severity of disease. However, CD64 index is not a good predictor for 28-day mortality in the critically ill patient.
CD64 seems to be a promising marker of infection in the intensive care setting, with Leuko64 showing a slight advantage
An elevated neutrophil CD64 index was a reliable prognostic biomarker for both short-term and long-term mortality in patients admitted for acute exacerbation of Chronic obstructive pulmonary disease.
Monocyte HLA-DR and neutrophil CD64 expression in critically ill infants with sepsis are related to age and infection.
The three-dimensional structure of a human IgG1 Fc fragment bound to wild-type human Fc-gamma RI is reported
FcgammaRI/FcgammaRIIB expression ratio in splenic macrophages was higher in the Treg-deficient immune thrombocytopenia (ITP (show ITPA ELISA Kits)) than in the Treg-deficient non-ITP (show ITPA ELISA Kits) and control mice
The IgG2 immune complexes activates osteoclastogenesis by binding to FcgammaRI.
Dbn1 regulates systemic anaphylaxis and IgE/Fcgr1-induced degranulation in mast cells by regulating actin reorganization and actin dynamics.
This study demonstrated that the activating FcgammaRs-mediated inflammation plays a critical role in anti-ganglioside Abs-induced neuropathy (injury to intact nerve fibers) in GBS (show GNB5 ELISA Kits).
N-glycans in FcgammaRIa interact with the OmpA of E. coli K1 for inducing disease pathogenesis
observations suggest that IgG-mediated inhibition of fibrocyte differentiation is mediated by FcgammaRs, with FcgammaRI mediating most of the signaling.
Inhibition of GCH1 (show GCH1 ELISA Kits) prevented the Escherichia coli K1 induced expression of CD64 in macrophages in vitro and the development of bacteremia in a newborn mouse model of meningitis.
The PI3K inhibitor LY294002 inhibited BCR (show BCR ELISA Kits)-mediated, but not TLR-mediated, induction of IkappaB-zeta (show NFKBIZ ELISA Kits), consistent with the role of PI3K in BCR (show BCR ELISA Kits) signaling and its suppression by FcgammaR.
Dap12 (show TYROBP ELISA Kits)- and FcRgamma (show FCER1G ELISA Kits)-deficiency exacerbates Granulocyte-Macrophage Colony-Stimulating Factor (show CSF2 ELISA Kits)-driven monocyte differentiation and production of inflammatory monocyte-derived dendritic cells.
This gene encodes a protein that plays an important role in the immune response. This protein is a high-affinity Fc-gamma receptor. The gene is one of three related gene family members located on chromosome 1.
Fc fragment of IgG, high affinity Ia, receptor for (CD64)
, Fc gamma receptor
, Fc-gamma RI
, Fc-gamma receptor I A1
, IgG Fc receptor I
, fc-gamma RIA
, high affinity immunoglobulin gamma Fc receptor I
, Fc fragment of IgG high affinity Ib receptor
, Fc fragment of IgG, high affinity Ib, receptor for (CD64)
, Fc receptor, IgG, high affinity I
, high affinity IgG Fc receptor, subunit beta
, high-affinity immunoglobulin gamma Fc receptor I
, IgG high affinity Fc receptor
, fc-gamma RI
, igG Fc receptor I
, FCGR1 variant 2
, FCGRI variant 1
, FCGRI variant 3